share_log

BTIG Maintains Buy on MDxHealth, Lowers Price Target to $7

Benzinga ·  May 16, 2023 07:27

BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $8 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment